Standard BioTools Inc. Operating Income
Standard BioTools Inc. (LAB) reported Operating Income of -$25.39 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-05
- Standard BioTools Inc. operating income (loss) for the quarter ending 2026-06-30 was -$25.39M.
- Standard BioTools Inc. operating income (loss) for the quarter ending 2026-03-31 was -$12.50M.
- Standard BioTools Inc. operating income (loss) for the quarter ending 2025-12-31 was -$24.64M.
- Standard BioTools Inc. operating income (loss) for the quarter ending 2025-09-30 was -$32.94M.
- Standard BioTools Inc. operating income (loss) for fiscal 2025 was -$110.25M.
- Standard BioTools Inc. operating income (loss) for fiscal 2024 was -$127.48M.
- Standard BioTools Inc. operating income (loss) for fiscal 2023 was -$76.60M.
- Standard BioTools Inc. operating income (loss) for fiscal 2022 was -$116.20M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$25.39M 10-Q · filed 2026-08-05 | -$37.88M 10-Q · filed 2026-08-05 | -$62.53M derived: sum of 3 quarters · filed 2026-08-05 | -$95.47M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | -$12.50M 10-Q · filed 2026-05-06 | -$37.14M derived: sum of 2 quarters · filed 2026-05-06 | -$70.08M derived: sum of 3 quarters · filed 2026-05-06 | -$95.78M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | -$24.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$57.58M derived: sum of 2 quarters · filed 2026-03-16 | -$83.28M derived: sum of 3 quarters · filed 2026-08-05 | -$110.25M 10-K · filed 2026-03-16 | ||||
| 2025-09-30 | -$32.94M 10-Q · filed 2025-11-04 | -$58.63M derived: sum of 2 quarters · filed 2026-08-05 | -$85.61M 10-Q · filed 2025-11-04 | -$111.69M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | -$25.70M 10-Q · filed 2026-08-05 | -$52.67M 10-Q · filed 2026-08-05 | -$78.75M derived: sum of 3 quarters · filed 2026-08-05 | -$105.45M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | -$26.97M 10-Q · filed 2026-05-06 | -$32.97M 10-Q · filed 2025-05-06 | -$53.05M derived: sum of 2 quarters · filed 2026-05-06 | -$79.75M derived: sum of 3 quarters · filed 2026-05-06 | -$110.01M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | -$26.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$52.78M derived: sum of 2 quarters · filed 2026-03-16 | -$83.04M derived: sum of 3 quarters · filed 2026-03-16 | -$127.48M 10-K · filed 2026-03-16 | -$175.24M 10-K · filed 2025-03-11 | |||
| 2024-09-30 | -$26.70M 10-Q · filed 2025-11-04 | -$31.72M 10-Q · filed 2024-11-06 | -$56.96M derived: sum of 2 quarters · filed 2025-11-04 | -$101.40M 10-Q · filed 2025-11-04 | -$142.42M 10-Q · filed 2024-11-06 | -$138.53M derived: sum of 4 quarters · filed 2026-03-16 | ||
| 2024-06-30 | -$30.26M 10-Q · filed 2025-08-15 | -$50.52M 10-Q · filed 2024-08-06 | -$74.70M 10-Q · filed 2025-08-15 | -$110.70M 10-Q · filed 2024-08-06 | -$111.83M derived: sum of 3 quarters · filed 2026-03-16 | -$133.00M derived: sum of 4 quarters · filed 2026-03-16 | ||
| 2024-03-31 | -$60.18M 10-Q · filed 2025-05-06 | -$81.57M derived: sum of 2 quarters · filed 2026-03-16 | -$102.74M derived: sum of 3 quarters · filed 2026-03-16 | -$120.19M derived: sum of 4 quarters · filed 2026-03-16 | ||||
| 2023-12-31 | -$21.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$42.56M derived: sum of 2 quarters · filed 2026-03-16 | -$60.01M derived: sum of 3 quarters · filed 2026-03-16 | -$76.60M 10-K · filed 2026-03-16 | ||||
| 2023-09-30 | -$21.17M 10-Q · filed 2024-11-06 | -$38.62M derived: sum of 2 quarters · filed 2024-11-06 | -$55.21M 10-Q · filed 2024-11-06 | -$76.33M derived: sum of 4 quarters · filed 2025-03-11 | ||||
| 2023-06-30 | -$17.45M 10-Q · filed 2024-08-06 | -$34.04M 10-Q · filed 2024-08-06 | -$55.15M derived: sum of 3 quarters · filed 2025-03-11 | -$84.18M derived: sum of 4 quarters · filed 2025-03-11 | ||||
| 2023-03-31 | -$16.59M 10-Q · filed 2024-05-09 | -$37.70M derived: sum of 2 quarters · filed 2025-03-11 | -$66.73M derived: sum of 3 quarters · filed 2025-03-11 | -$105.30M derived: sum of 4 quarters · filed 2025-03-11 | ||||
| 2022-12-31 | -$21.11M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$50.14M derived: sum of 2 quarters · filed 2025-03-11 | -$88.70M derived: sum of 3 quarters · filed 2025-03-11 | -$116.20M 10-K · filed 2025-03-11 | ||||
| 2022-09-30 | -$29.03M 10-Q · filed 2023-11-07 | -$67.59M derived: sum of 2 quarters · filed 2023-11-07 | -$95.09M 10-Q · filed 2023-11-07 | -$106.35M derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | -$38.56M 10-Q · filed 2023-08-08 | -$66.07M 10-Q · filed 2023-08-08 | -$77.33M derived: sum of 3 quarters · filed 2023-08-08 | -$96.94M derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | -$27.50M 10-Q · filed 2023-05-09 | -$38.76M derived: sum of 2 quarters · filed 2023-05-09 | -$58.37M derived: sum of 3 quarters · filed 2023-05-09 | -$75.64M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | -$11.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$30.87M derived: sum of 2 quarters · filed 2023-03-14 | -$48.14M derived: sum of 3 quarters · filed 2023-03-14 | -$67.46M 10-K · filed 2023-03-14 | ||||
| 2021-09-30 | -$19.61M 10-Q · filed 2022-11-09 | -$36.88M derived: sum of 2 quarters · filed 2022-11-09 | -$56.20M 10-Q · filed 2022-11-09 | -$73.10M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | -$17.27M 10-Q · filed 2022-08-09 | -$36.59M 10-Q · filed 2022-08-09 | -$53.49M derived: sum of 3 quarters · filed 2022-08-09 | -$58.96M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | -$19.32M 10-Q · filed 2022-05-09 | -$36.22M derived: sum of 2 quarters · filed 2022-05-09 | -$41.69M derived: sum of 3 quarters · filed 2022-05-09 | -$55.41M derived: sum of 4 quarters · filed 2022-05-09 | ||||
| 2020-12-31 | -$16.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | -$22.37M derived: sum of 2 quarters · filed 2022-03-08 | -$36.09M derived: sum of 3 quarters · filed 2022-03-08 | -$51.04M 10-K · filed 2022-03-08 | ||||
| 2020-09-30 | -$5.46M 10-Q · filed 2021-11-09 | -$19.19M derived: sum of 2 quarters · filed 2021-11-09 | -$34.13M 10-Q · filed 2021-11-09 | -$43.31M derived: sum of 4 quarters · filed 2022-03-08 | ||||
| 2020-06-30 | -$13.73M 10-Q · filed 2021-08-06 | -$28.67M 10-Q · filed 2021-08-06 | -$37.85M derived: sum of 3 quarters · filed 2022-03-08 | -$51.66M derived: sum of 4 quarters · filed 2022-03-08 | ||||
| 2020-03-31 | -$14.94M 10-Q · filed 2021-05-07 | -$24.12M derived: sum of 2 quarters · filed 2022-03-08 | -$37.94M derived: sum of 3 quarters · filed 2022-03-08 | -$52.58M derived: sum of 4 quarters · filed 2022-03-08 | ||||
| 2019-12-31 | -$9.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | -$23.00M derived: sum of 2 quarters · filed 2022-03-08 | -$37.63M derived: sum of 3 quarters · filed 2022-03-08 | -$51.84M 10-K · filed 2022-03-08 | ||||
| 2019-09-30 | -$13.82M 10-Q · filed 2020-11-09 | -$28.45M derived: sum of 2 quarters · filed 2020-11-09 | -$42.66M 10-Q · filed 2020-11-09 | -$53.78M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | -$14.64M 10-Q · filed 2020-08-07 | -$28.84M 10-Q · filed 2020-08-07 | -$39.96M derived: sum of 3 quarters · filed 2021-02-25 | -$51.59M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | -$14.21M 10-Q · filed 2020-05-11 | -$25.32M derived: sum of 2 quarters · filed 2021-02-25 | -$36.95M derived: sum of 3 quarters · filed 2021-02-25 | -$49.74M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | -$11.12M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$22.75M derived: sum of 2 quarters · filed 2021-02-25 | -$35.53M derived: sum of 3 quarters · filed 2021-02-25 | -$48.16M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | -$11.63M 10-Q · filed 2019-11-08 | -$24.41M derived: sum of 2 quarters · filed 2019-11-08 | -$37.05M 10-Q · filed 2019-11-08 | -$45.78M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | -$12.79M 10-Q · filed 2019-08-07 | -$25.42M 10-Q · filed 2019-08-07 | -$34.15M derived: sum of 3 quarters · filed 2020-02-27 | -$49.76M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | -$12.63M 10-Q · filed 2019-05-07 | -$21.37M derived: sum of 2 quarters · filed 2020-02-27 | -$36.97M derived: sum of 3 quarters · filed 2020-02-27 | -$53.46M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | -$8.73M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$24.34M derived: sum of 2 quarters · filed 2020-02-27 | -$40.82M derived: sum of 3 quarters · filed 2020-02-27 | -$58.36M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | -$15.60M 10-Q · filed 2018-11-06 | -$32.09M derived: sum of 2 quarters · filed 2018-11-06 | -$49.63M 10-Q · filed 2018-11-06 | -$67.32M derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2017-06-30 | -$16.49M 10-Q · filed 2018-08-08 | -$34.02M 10-Q · filed 2018-08-08 | -$51.72M derived: sum of 3 quarters · filed 2019-03-18 | -$70.20M derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2017-03-31 | -$17.54M 10-Q · filed 2018-05-08 | -$35.23M derived: sum of 2 quarters · filed 2019-03-18 | -$53.72M derived: sum of 3 quarters · filed 2019-03-18 | -$71.86M derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2016-12-31 | -$17.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$36.18M derived: sum of 2 quarters · filed 2019-03-18 | -$54.32M derived: sum of 3 quarters · filed 2019-03-18 | -$73.19M 10-K · filed 2019-03-18 | ||||
| 2016-09-30 | -$18.48M 10-Q · filed 2017-11-07 | -$36.63M derived: sum of 2 quarters · filed 2017-11-07 | -$55.49M 10-Q · filed 2017-11-07 | -$69.19M derived: sum of 4 quarters · filed 2018-03-08 | ||||
| 2016-06-30 | -$18.14M 10-Q · filed 2017-08-08 | -$37.01M 10-Q · filed 2017-08-08 | -$50.70M derived: sum of 3 quarters · filed 2018-03-08 | -$58.51M derived: sum of 4 quarters · filed 2018-03-08 | ||||
| 2016-03-31 | -$18.87M 10-Q · filed 2017-05-09 | -$32.56M derived: sum of 2 quarters · filed 2018-03-08 | -$40.36M derived: sum of 3 quarters · filed 2018-03-08 | -$55.02M derived: sum of 4 quarters · filed 2018-03-08 | ||||
| 2015-12-31 | -$13.69M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$21.50M derived: sum of 2 quarters · filed 2018-03-08 | -$36.15M derived: sum of 3 quarters · filed 2018-03-08 | -$50.16M 10-K · filed 2018-03-08 | ||||
| 2015-09-30 | -$7.80M 10-Q · filed 2016-11-09 | -$22.46M derived: sum of 2 quarters · filed 2016-11-09 | -$36.46M 10-Q · filed 2016-11-09 | -$46.30M derived: sum of 4 quarters · filed 2017-03-03 | ||||
| 2015-06-30 | -$14.66M 10-Q · filed 2016-08-09 | -$28.66M 10-Q · filed 2016-08-09 | -$38.49M derived: sum of 3 quarters · filed 2017-03-03 | -$51.54M derived: sum of 4 quarters · filed 2017-03-03 | ||||
| 2015-03-31 | -$14.00M 10-Q · filed 2016-05-09 | -$23.83M derived: sum of 2 quarters · filed 2017-03-03 | -$36.88M derived: sum of 3 quarters · filed 2017-03-03 | -$49.26M derived: sum of 4 quarters · filed 2017-03-03 | ||||
| 2014-12-31 | -$9.83M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | -$22.88M derived: sum of 2 quarters · filed 2017-03-03 | -$35.26M derived: sum of 3 quarters · filed 2017-03-03 | -$51.84M 10-K · filed 2017-03-03 | ||||
| 2014-09-30 | -$13.05M 10-Q · filed 2015-11-09 | -$25.42M derived: sum of 2 quarters · filed 2015-11-09 | -$42.00M 10-Q · filed 2015-11-09 | -$46.65M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | -$12.38M 10-Q · filed 2015-08-10 | -$28.96M 10-Q · filed 2015-08-10 | -$33.60M derived: sum of 3 quarters · filed 2016-02-29 | -$38.55M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | -$16.58M 10-Q · filed 2015-05-11 | -$21.22M derived: sum of 2 quarters · filed 2016-02-29 | -$26.18M derived: sum of 3 quarters · filed 2016-02-29 | -$30.16M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | -$4.64M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$9.60M derived: sum of 2 quarters · filed 2016-02-29 | -$13.59M derived: sum of 3 quarters · filed 2016-02-29 | -$18.65M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | -$4.95M 10-Q · filed 2014-11-06 | -$8.94M derived: sum of 2 quarters · filed 2014-11-06 | -$14.01M 10-Q · filed 2014-11-06 | -$17.50M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-06-30 | -$3.99M 10-Q · filed 2014-08-04 | -$9.06M 10-Q · filed 2014-08-04 | -$12.55M derived: sum of 3 quarters · filed 2015-02-26 | -$16.46M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-03-31 | -$5.07M 10-Q · filed 2014-05-12 | -$8.56M derived: sum of 2 quarters · filed 2015-02-26 | -$12.47M derived: sum of 3 quarters · filed 2015-02-26 | -$16.86M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2012-12-31 | -$3.49M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | -$7.40M derived: sum of 2 quarters · filed 2015-02-26 | -$11.79M derived: sum of 3 quarters · filed 2015-02-26 | -$18.07M 10-K · filed 2015-02-26 | ||||
| 2012-09-30 | -$3.91M 10-Q · filed 2013-11-07 | -$8.29M derived: sum of 2 quarters · filed 2013-11-07 | -$14.58M 10-Q · filed 2013-11-07 | -$17.56M derived: sum of 4 quarters · filed 2014-03-12 | ||||
| 2012-06-30 | -$4.39M 10-Q · filed 2013-08-07 | -$10.67M 10-Q · filed 2013-08-07 | -$13.65M derived: sum of 3 quarters · filed 2014-03-12 | -$17.70M derived: sum of 4 quarters · filed 2014-03-12 | ||||
| 2012-03-31 | -$6.28M 10-Q · filed 2013-05-09 | -$9.26M derived: sum of 2 quarters · filed 2014-03-12 | -$13.32M derived: sum of 3 quarters · filed 2014-03-12 | -$19.97M derived: sum of 4 quarters · filed 2014-03-12 | ||||
| 2011-12-31 | -$2.98M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12 | -$7.03M derived: sum of 2 quarters · filed 2014-03-12 | -$13.69M derived: sum of 3 quarters · filed 2014-03-12 | -$18.57M 10-K · filed 2014-03-12 | ||||
| 2011-09-30 | -$4.05M 10-Q · filed 2012-11-09 | -$10.71M derived: sum of 2 quarters · filed 2012-11-09 | -$15.59M 10-Q · filed 2012-11-09 | -$17.60M derived: sum of 4 quarters · filed 2013-03-12 | ||||
| 2011-06-30 | -$6.65M 10-Q · filed 2012-08-14 | -$11.53M 10-Q · filed 2012-08-14 | -$13.54M derived: sum of 3 quarters · filed 2013-03-12 | -$16.64M derived: sum of 4 quarters · filed 2013-03-12 | ||||
| 2011-03-31 | -$4.88M 10-Q · filed 2012-05-15 | -$6.89M derived: sum of 2 quarters · filed 2013-03-12 | -$9.99M derived: sum of 3 quarters · filed 2013-03-12 | -$14.21M derived: sum of 4 quarters · filed 2013-03-12 | ||||
| 2010-12-31 | -$2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | -$5.11M derived: sum of 2 quarters · filed 2013-03-12 | -$9.34M derived: sum of 3 quarters · filed 2013-03-12 | -$14.57M 10-K · filed 2013-03-12 | ||||
| 2010-09-30 | -$3.10M 10-Q · filed 2011-11-14 | -$7.33M derived: sum of 2 quarters · filed 2011-11-14 | -$12.56M 10-Q · filed 2011-11-14 | |||||
| 2010-06-30 | -$4.23M 10-Q · filed 2011-08-09 | -$9.46M 10-Q · filed 2011-08-09 | ||||||
| 2009-12-31 | -$18.04M 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |